BRK.B vs ABBV Stock Comparison

BRK.B currently leads ABBV in this stock comparison, with AIQ scores of 85 vs 56. The clearest difference is risk resilience.

Market data as of Oct 21, 2026 market close· AIQ score gap 29 points
BRK.B
Stock
vs
ABBV
Healthcare
BRK.B
BRK.B
Leads
Price
$539
Day move
-0.15%
AIQ Score
85/100
Best edge
Risk Resilience
Sector
-
ABBV
AbbVie Inc.
Price
$285
Day move
-1.48%
AIQ Score
56/100
Best edge
Balanced
Sector
Healthcare

What is the main difference between BRK.B and ABBV?

BRK.B leads the current stock comparison as BRK.B, with the clearest separation coming from risk resilience and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

BRK.B vs AbbVie Inc.

Data as of Oct 21, 2026· market close· ABBV: Healthcare· Coverage 55/66 fields· Moderate confidence
AIQ VerdictFragileAIQ Comparison Conviction 7/10

BRK.B leads

BRK.B leads by 29 AIQ points, primarily on Risk Resilience and Momentum, having only recently taken the lead back from ABBV.

Fragile: 3 of 4 evidence groups support BRK.B, the lead recently changed hands, and its current signal state is conflicted.

Evidence agreement: 3 of 4Comparison trend: Reversed
Leads
AIQ Score
85/100
AIQ Edge Score
10/10
ABBV

AbbVie Inc.

AIQ Score
56/100
AIQ Edge Score
6/10

The Algovestiq AIQ Score currently favors BRK.B over ABBV, 85 versus 56 as of Oct 21, 2026. BRK.B's advantage is driven primarily by stronger risk resilience and momentum. BRK.B also shows the weaker technical structure relative to its 50-day moving average. 3 of 4 covered evidence groups favor BRK.B today, and the comparison is rated Fragile on stability: the lead has already changed hands inside the comparison window. BRK.B lead: Reversed — ABBV led by 1 AIQ points 30 sessions ago; BRK.B now leads by 29.

Compare BRK.B and AbbVie Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

BRK.B
+86.0%
ABBV
+218.5%

Total return comparison

Growth of $10,000, distributions reinvested

BRK.B $18,598 · ABBV $31,853

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare BRK.B and ABBV against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

BRK.B advantage
0
ABBV advantage
  • Risk Resilience79 vs 44
    BRK.B +35
  • Momentum89 vs 84
    BRK.B +5

3 of 4 evidence groups favor BRK.B. BRK.B’s edge is concentrated in risk resilience and momentum.

What changed since the last close

Latest scored session 2026-10-20, compared against the prior scored session 2026-10-19.

BRK.B0 AIQ

Largest factor move: Momentum +1, not enough on its own to move the overall score.

New signals

  • BB Upper Band Breach — bearish, volatility, short horizon
ABBV0 AIQ

Largest factor move: Momentum +1, not enough on its own to move the overall score.

New signals

  • Keltner Channel Breakout — bullish, volatility, short horizon

BRK.B's lead was unchanged in the latest session.

Deeper signal detail for each name lives on its own signals page — BRK.B and ABBV both carry a full feed there.

The central trade-off

BRK.B (BRK.B): the stronger current systematic profile, led by risk resilience and momentum.

ABBV (AbbVie Inc.): the counter-case, on technicals — but at materially higher volatility, 20.9% against 9.5%.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

BRK.B

BRK.B on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

Even

Growth figures are not covered for both names.

Value

Even

The two are level on Value.

Momentum

BRK.B

BRK.B on the Momentum factor, by 5 points.

Lower downside

BRK.B

BRK.B on Risk Resilience, by 35 points.

Analyst upside

BRK.B

BRK.B on implied upside to the consensus price target.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureBRK.BABBVNote
Implied upside to target+6.7%+0.9%BRK.B has more room
Target dispersion0%+29.6%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering114Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

3 of 4 covered evidence groups favor BRK.B. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreBRK.B85 vs 56
FundamentalsNot coveredNot covered
ValuationNot coveredNot covered
TechnicalsABBVPrice vs 50-day 5.9% vs 7.9%; vs 200-day 7.8% vs 21.9%
Risk ResilienceBRK.BRisk Resilience 79 vs 44
Analyst expectationsBRK.BTarget upside 6.7% vs 0.9%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of BRK.B and ABBV and are excluded from the count.

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • The AIQ gap is wide at 29 points. (supports the conclusion holding)
  • The lead has already changed hands inside the comparison window. (argues the conclusion is provisional)
  • The lead has swung materially session to session. (argues the conclusion is provisional)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on BRK.B.

How the comparison changed

120 daily snapshots · Jun 21 – Oct 20

BRK.B lead: Reversed — ABBV led by 1 AIQ points 30 sessions ago; BRK.B now leads by 29.

Jun 21BRK.B leads above the line · ABBV leads belowOct 20
Today
BRK.B +29
85 vs 56
7 sessions ago
BRK.B +27
84 vs 57
30 sessions ago
ABBV +1
54 vs 55
90 sessions ago
ABBV +2
44 vs 46

The lead changed hands 5 times in this window, most recently on Oct 7 when BRK.B moved ahead of ABBV.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

BRK.BConflicted

6 bullish / 2 bearish / 1 neutral, conflicted

Only BRK.B

  • ATR Contraction - Coiling — neutral, volatility, short horizon (1.14%)
  • BB Upper Band Breach — bearish, volatility, short horizon
ABBVConflicted

6 bullish / 1 bearish, conflicted

No signal that the other name lacks.

Both carry 7 more signals that do not separate them: Golden Cross Active, Keltner Channel Breakout, RSI Overbought, EMA Ribbon Expansion Bullish, 52-Week High Proximity, Uptrend Structure Active, MACD Bullish Crossover.

BRK.B leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

BRK.BNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.15%, AIQ 0 points).

ABBVNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -1.48%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1ABBV closes the Risk Resilience gap — currently 35 points behind, the largest single contributor to BRK.B's edge.
  2. 2ABBV's RSI Overbought resolves — a bearish momentum rule currently active against it.
  3. 3BRK.B's conflicting signal state resolves bearish — it currently carries 6 bullish and 2 bearish rules at once.
  4. 4A regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

Split
MetricBRK.BABBV
Revenue growth (YoY)—13.3%
EPS growth (YoY)—4.2%
Gross margin—71.5%
Operating margin—29.3%
Return on equity (TTM)—-136.5%
Debt to equity—-11.93

Performance

ABBV leads 6 of 6 windows
MetricBRK.BABBV
1 week (5 sessions)3.7%5.4%
1 month (20 sessions)7.2%9%
3 months (63 sessions)10.3%14.1%
6 months (126 sessions)12.2%37.3%
Year to date6.1%25.3%
1 year (252 sessions)10.4%27.4%

Technicals

ABBV has the stronger structure
MetricBRK.BABBV
RSI (14)8877.5
ADX (14)28.433.9
Price vs 50-day5.9%7.9%
Price vs 200-day7.8%21.9%
Volatility (1M, annualized)9.5%20.9%

Risk

BRK.B is the more resilient
MetricBRK.BABBV
Beta-0.05-0.14
Sharpe ratio0.430.87
Sortino ratio0.621.39
Max drawdown-9.4%-16.5%
Current drawdown0%0%
Annualized volatility14.7%25.9%
Value at risk (95%)-1.4%-2.4%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, BRK.B or ABBV?

On the Algovestiq AIQ Score, BRK.B is the stronger of the two as of Oct 21, 2026, scoring 85 against ABBV's 56. The edge comes from risk resilience and momentum. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is BRK.B or ABBV the better buy right now?

BRK.B carries the stronger systematic profile as of Oct 21, 2026, and the comparison is rated Fragile — 3 of 4 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the lead has already changed hands inside the comparison window. Treat the lead as provisional.

Why does the AIQ Score favor BRK.B over ABBV?

The composite weights Quality, Value, Momentum and Risk Resilience. BRK.B leads Risk Resilience by 35 points; BRK.B leads Momentum by 5 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, BRK.B or ABBV?

Analyst price targets imply +6.7% upside for BRK.B and +0.9% for ABBV, so the Street currently favors BRK.B. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, BRK.B or ABBV?

Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, BRK.B or ABBV?

Growth figures are not covered for both names. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, BRK.B or ABBV?

BRK.B on the Momentum factor, by 5 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, BRK.B or ABBV?

BRK.B is the more resilient of the two, so the other name carries the higher downside risk. BRK.B on Risk Resilience, by 35 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is BRK.B more profitable than ABBV?

Margin data is not comparable for both names in the current snapshot.

Is BRK.B's lead over ABBV getting stronger or weaker?

BRK.B lead: Reversed — ABBV led by 1 AIQ points 30 sessions ago; BRK.B now leads by 29. This is measured from 120 daily comparison snapshots between 2026-06-21 and 2026-10-20. The lead has changed hands 5 times in that window, most recently on 2026-10-07, when BRK.B moved ahead of ABBV.

What would change the BRK.B vs ABBV verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: ABBV closes the Risk Resilience gap — currently 35 points behind, the largest single contributor to BRK.B's edge; ABBV's RSI Overbought resolves — a bearish momentum rule currently active against it; BRK.B's conflicting signal state resolves bearish — it currently carries 6 bullish and 2 bearish rules at once; a regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.

What do the current signals say about BRK.B and ABBV?

BRK.B: 6 bullish / 2 bearish / 1 neutral, conflicted. ABBV: 6 bullish / 1 bearish, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on BRK.B is Golden Cross Active (bullish, long horizon). On ABBV it is Golden Cross Active (bullish, long horizon).

Compare BRK.B and ABBV with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.